Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ziv-aflibercept
Find trials that include:  Any drugs shown
Results 1-10 of 10 for your search:
Start Over
Capecitabine and Ziv-Aflibercept in Treating Patients with Refractory Solid Tumors or Metastatic Colorectal Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00037688, NCI-2013-00472, NCT01661972
Aldesleukin with or without Ziv-Aflibercept in Treating Patients with Stage III-IV Melanoma That Cannot Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: Over 16
Trial IDs: PhII-107, NCI-2011-02498, CDR0000690654, CHNMC-PHII-107, 8628, NCT01258855
Ziv-Aflibercept and Combination Chemotherapy in Treating Patients with Previously Untreated Colorectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU 11182, NCI-2012-01167, 2012C0055, NCT01652196
Ziv-aflibercept and Octreotide Pamoate in Treating Patients with Metastatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-456, NCI-2013-00620, AFLIBL06140, NCT01782443
Ziv-aflibercept, Capecitabine, and Oxaliplatin as Front-Line Therapy in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 13-145, NCI-2014-00894, NCI-2014-00687, NCT02079220
MLN0128 and Ziv-Aflibercept in Treating Patients with Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0665, NCI-2014-01107, 9585, NCT02159989
Ganetespib and Ziv-Aflibercept in Treating Patients with Refractory or Metastatic Gastrointestinal Cancer, Non-small Cell Lung Cancer, Urothelial Cancer, or Sarcoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: 14-C-0150, NCI-2014-00626, 141525, 9605, NCT02192541
Pembrolizumab and Ziv-aflibercept in Treating Patients with Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9676, NCI-2014-01984, NCT02298959
Intravitreal Aflibercept Injection for Radiation Retinopathy
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201209108, NCI-2013-00478, RA-001, NCT01579760
Start Over